Effect of Neurostimulator Usage on Block Success

NCT ID: NCT05706090

Last Updated: 2023-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-01

Study Completion Date

2021-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The need of a neurostimulator for a successful nerve block was questioned in different block types after ultrasound has become standard. The aim of this clinical study was to determine the effect of neurostimulator use on block success in costoclavicular block

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PATIENTS WITH UPPER EXTREMITY SURGERY

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Brachial Plexus Block; Nerve Block; Ultrasonography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group USP

The group using ultrasound and injection pressure manometer was named USP

Group Type EXPERIMENTAL

fentanyl will be added

Intervention Type DRUG

If adequate anagesia is not provided with the block, 1 microgram/kg of fentanyl will be added

general anesthesia

Intervention Type PROCEDURE

If adequate anagesia is not provided with the block, general anesthesia will be administered.

Group USPN

The group using ultrasound , injection pressure manometer , and neurostimulator was named USPN

Group Type EXPERIMENTAL

fentanyl will be added

Intervention Type DRUG

If adequate anagesia is not provided with the block, 1 microgram/kg of fentanyl will be added

general anesthesia

Intervention Type PROCEDURE

If adequate anagesia is not provided with the block, general anesthesia will be administered.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fentanyl will be added

If adequate anagesia is not provided with the block, 1 microgram/kg of fentanyl will be added

Intervention Type DRUG

general anesthesia

If adequate anagesia is not provided with the block, general anesthesia will be administered.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Class I, II and III of American Society of Anesthesiologists (ASA) classification
* being between 18 and 80 years of age,
* body mass index (BMI) between 18 and 35 kg/m2

Exclusion Criteria

* Patients who did not give consent,
* were above ASA III,
* pregnant,
* had a neuromuscular disease,
* bleeding diathesis,
* a local anesthetic allergy,
* an infection in the area where nerve block would be applied, and
* had previously operated from the infraclavicular fossa were not included in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Döndü Genc Moralar

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gazoosmanpasa Education and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Neurostimulator Usage

Identifier Type: -

Identifier Source: org_study_id